Hints and tips:
Related Special Reports
...WPP’s Ogilvy advertising agency is creating a division specialising in online “health influencers” to help pharmaceutical companies tap a trend towards personalised health and combat misinformation....
...Duato has previously said J&J would aggressively pursue deals in high-growth segments of the business, such as its medical technology division....
...He was previously chief of the Roche diagnostics business, and is now focusing on improving the future of the pharmaceutical division with internal development and deals, after disappointments including...
...The reforms have been fiercely resisted by the pharmaceutical industry, which has warned they would cripple innovation and hinder development of life-saving medicines....
...The asset management division of BNP Paribas, the French banking group, has sent letters to 14 of the world’s largest pharmaceutical companies asking them to use a cloned substance called recombinant factor...
...division....
...It also apologised for the trouble to its customers and stakeholders....
...The US drugmaker has spent almost $30bn on acquisitions over the past two years, snapping up Arena Pharmaceuticals, Biohaven Pharmaceuticals, Global Blood Therapeutics, ReViral and Trillium Therapeutics....
...The company is eager to resolve the uncertainty regarding the talc claims before it spins off its consumer health division in coming months....
...Its key target in moving “beyond nicotine”, to generate $1bn in revenues from its wellness and healthcare division by 2025, is “questionable”, he admitted. Vectura’s figures aren’t disclosed....
...” in pharmaceuticals....
...When the US drugs company Abbott Laboratories acquired a small division of the German chemicals group BASF for $6.9bn 23 years ago, its shares fell on fears that it had overpaid....
...Janssen is the pharmaceutical division of J&J....
...Bruce Liu, who leads the life sciences division for China at the consultancy Simon-Kucher & Partners, said it was unlikely that Beijing and Pfizer could strike a deal on pricing....
...One has to wonder why J&J, which is in the midst of spinning off its consumer products division, felt the need to do a deal now. Sure, it is sitting on $34bn of cash and equivalent....
...Pfizer said it would build a factory in China to manufacture Paxlovid with a local partner, but the US pharmaceutical giant hinted that it was unlikely to lower the drug’s price — a condition to permanent...
...New Jersey-based J&J said the Abiomed deal would broaden its medical technology division and hone its focus on cardiovascular disease....
...Spinning off its Sandoz division would create the largest generic drugs company in Europe by sales, Novartis said on Thursday, as it set out one of its most significant moves to focus on faster-growing and...
...Strong sales of its cancer treatment Darzalex and other drugs helped to offset a weaker performance by the company’s medical devices division, which has been buffeted by Covid-related disruptions....
...Gabriel Harnier group general counsel, BAYER Three years ago, under Harnier’s leadership, the legal team at Bayer, the German pharmaceuticals and life sciences company, moved its contracting, data privacy...
...When Joe Biden was elected US president, it soon became clear the pharmaceutical and biotech sectors would face tougher regulation....
...Amazon is trimming 3 per cent of its corporate workforce, mostly from unprofitable divisions....
...’s active pharmaceutical ingredients — has helped it forge a new role as an innovative drug hub....
...Regeneron, though, is hardly a mom-and-pop business. It has a market value of $60bn....
...Johnson & Johnson is to spin off its consumer products division, best known for Band-Aids and baby shampoo, as the world’s largest healthcare company seeks to focus on pharmaceuticals and medical devices...
International Edition